Full-Life Technologies raises $150M; Quince's reboot with pulmonary drug
Plus, news about Accro Bioscience, Hansa Biopharma, Shanghai Best-Link Bioscience and UCB.
Full-Life Technologies gets $150M: The radiotherapy company has raised $110 million in a Series D round and another $40 ...
Read the full article on the original site.
Read Full Article